A Safer Blood Thinner? 

This novel blood clot treatment doesn't increase bleeding risk

Health & Lifestyle
221

Listen to article (english)

Translate to Spanish or other 102 languages!

Future blood thinners may no longer increase the risk of bleeding if further studies confirm the potential of a new compound. Image for illustration purposes
Future blood thinners may no longer increase the risk of bleeding if further studies confirm the potential of a new compound. Image for illustration purposes

Medical News Today

- Advertisement -
  • While anticoagulants are important for preventing dangerous blood clots, they increase the risk of excessive bleeding.
  • Future blood thinners may no longer increase the risk of bleeding if further studies confirm the potential of a new compound.
  • Rather than target all clotting pathways to prevent thrombosis, the new compound strategically targets just one, so clotting continues but without a bleeding risk or toxicity.

Anticoagulants, or blood thinners, break down and prevent blood clots, semi-solid clumps of blood cells, and other substances that can block blood flow. However, anticoagulants can do their job too well, preventing clotting altogether and resulting in excessive external or internal bleeding.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/blood-thinner-potential-blood-clot-treatment-lower-bleeding-risk?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-05-02&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Hispanic People – Especially Men – Are Less Likely to See a Doctor
Next article
Why Young Women Have More Adverse Outcomes After a Heart Attack Than Young Men

More Articles

FDA Launches Expedited IND Pilot to Speed Up Clinical Trials

The U.S. Food and Drug Administration today announced the final design of the Expedited Investigational New Drug (IND) Pilot. Accelerating clinical trial timelines and eliminating regulatory hurdles to maintain American leadership in global medical innovation is a core priority for the Trump Administration.

Navigating Cardiovascular Health in Hispanic Communities

Cardiovascular disease is the leading cause of death for Hispanic and Latino people in the United States. But the challenges they face are hardly the whole story, say experts who helped write a new report on the heart health of these communities.

Easy Ways to Turn Picky Eaters Into Happy Eaters

September is National Fruits and Veggies Month. If you have a little one who isn’t a big fan of either, you’re in good company. It’s common for kids to be picky eaters.

New AI Tool Accurately Predicts Lung Cancer Immunotherapy Results

Artificial intelligence (AI) tools can help physicians predict treatment and survival outcomes in patients with advanced non-small cell lung cancer (NSCLC) treated with immunotherapy, according to a new study published in Nature Medicine.
- Advertisement -